A detailed history of Inspire Investing, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Inspire Investing, LLC holds 24,798 shares of COLL stock, worth $958,194. This represents 0.09% of its overall portfolio holdings.

Number of Shares
24,798
Previous 21,881 13.33%
Holding current value
$958,194
Previous $849,000 6.01%
% of portfolio
0.09%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$31.36 - $39.99 $91,477 - $116,650
2,917 Added 13.33%
24,798 $798,000
Q1 2024

May 07, 2024

SELL
$31.23 - $40.91 $108,867 - $142,612
-3,486 Reduced 13.74%
21,881 $849,000
Q4 2023

Feb 12, 2024

SELL
$21.16 - $30.8 $52,328 - $76,168
-2,473 Reduced 8.88%
25,367 $780,000
Q3 2023

Oct 26, 2023

BUY
$21.23 - $24.28 $18,533 - $21,196
873 Added 3.24%
27,840 $622,000
Q2 2023

Jul 31, 2023

BUY
$21.06 - $24.0 $567,925 - $647,208
26,967 New
26,967 $579,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.32B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.